openPR Logo
Press release

Diffuse Large B-Cell Lymphoma Market | AstraZeneca plc, Astellas Pharma, Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd

06-17-2019 08:46 AM CET | Health & Medicine

Press release from: TMR Research

Diffuse Large B-Cell Lymphoma Market | AstraZeneca plc,

The Research Report on ” Diffuse Large B-Cell Lymphoma Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017 - 2025 “, issued by TMR Research, includes a detailed qualitative and quantitative analysis of the market, with the help of information collected from market participants operating across key sectors of the market value chain.

Diffuse Large B-Cell Lymphoma Market: Overview

With a noticeable rise in the prevalence of diffuse large B-cell lymphoma (DLBCL), the market for DLBCL market is witnessing strong growth across the world. Analysts expect the trend to remain so over the next few years, owing to the increasing number of elderly people, the most prone to DLBCL segment of the overall population.

Request Sample At: https://www.tmrresearch.com/sample/sample?flag=B&rep_id=494

Diffuse large B-cell lymphoma (DLBCL) is the most common form of non hodgkin lymphoma (NHL) and is the main reason behind more than 30% of the newly diagnosed cancer cases in the U.S. alone. The prevalence of this disease is increasing at an alarming rate, which is likely to fuel the demand for DLBCL treatments substantially in the near future, leading to a considerable diffuse large B-Cell lymphoma market growth.

This research report offers a detailed evaluation of the global diffuse large B-Cell lymphoma market on the basis of its current and historical performance. The prominent trends, growth drivers, challenges, opportunities, and the future prospects of this market have also been examined thoroughly while conducting this study. The main objective of this study is to assist the market participants in gaining a clear and deep insight into this market.

Global Diffuse Large B-cell Lymphoma Market: Snapshot

Lymphoma is a type of cancer affecting the human lymphatic system, a part of our immune system. The development of lymphoma begins when a type of white bold cell, lymphocytes commence to divide in an uncontrolled manner. Although there are two chief kinds of lymphocytes, T lymphocytes and B lymphocytes, B cells tend to be responsible for most lymphomas. Diffuse large B-cell lymphoma (DLBCL) develop from B cells that are abnormal, larger sized cells which are different from healthy, normal B cells. These abnormal cells spread out diffusely all over the tumor, wiping out the lymph node’s normal structure.

More than 4,800 people in the U.K. are diagnosed with diffuse large B-cell lymphoma every year, according to the U.K. Lymphoma Association. The disease can occur at any age, affecting children as well. However, the aged population is at a higher risk of developing diffuse large B-cell lymphoma. Several patients initially notice painless lumps, usually in their neck, groin, or armpit. Apart from this, loss of appetite, itching, and fatigue are also some other common symptoms.

The continuous development of novel treatments and drugs for treating diffuse large B-cell lymphoma via research and development is assisting the growth of the global diffuse large B-Cell lymphoma market. For instance, in May 2017, it was announced that a rare sub-type of DLBCL, primary mediastinal B-cell lymphoma, can be treated through the use of pembrolizumab, a PD-1 inhibitor. An evaluation of 18 participants with diffuse large B-cell lymphoma under KEYNOTE 013 revealed the safety and efficacy of pembrolizumab.

Request TOC of the Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=494

Diffuse Large B-Cell Lymphoma Market: Trends and Opportunities

The increasing incidence of DLBCL has fueled the demand for efficient therapies for its treatment across the world. With the ever-rising global geriatric population, the scenario is likely to remain more or less similar over the forthcoming years. In addition, the presence of a robust last stage pipeline of drugs ready for clinical trials and the increasing expenditure on healthcare are expected to boost this market tremendously in the years to come.

At present, the most efficient treatment for DLBCL available across the world is combination therapy that includes chemotherapy and monoclonal antibody-based drug Rituxan (rituximab). However, the development of other drugs is also taking place at a swift pace, with many of them being in various late-stage clinical trials. Alisertib (MLN8237), Bortezomib (Velcade), Brentuximab vedotin (Adcetris), Everolimus (Afinitor), Lenalidomide (Revlimid), Panobinostat, and Vorinostat (Zolinza) are some of the key pipelined projects, approval of which will gain advantages for this market in the forthcoming years.

Diffuse Large B-Cell Lymphoma Market: Geographical Analysis

North America, followed by Europe, has surfaced as the leading contributor to the global diffuse large B-Cell lymphoma market, thanks to the high prevalence of DLBCL, rising awareness level of people, and their increased disposable income. However, Asia Pacific is likely to emerge as the most promising regional market in the coming years. The strengthening economy and the improving healthcare infrastructure in this region are expected to act as the key driving force behind the growth of the Asia Pacific diffuse large B-Cell lymphoma market.

Diffuse Large B-Cell Lymphoma Market: Companies Mentioned in the Report

Some of the major players operating in diffuse large B-Cell lymphoma market are Amgen, Inc., AstraZeneca plc, Astellas Pharma, Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Gilead Sciences, Inc., Genentech, Inc., Infinity Pharmaceuticals, Inc., MedImmune, LLC, Merck & Co., Inc., Novartis AG and Sanofi.

About TMR Research:

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Contact:

TMR Research,
3739 Balboa St # 1097,
San Francisco, CA 94121
United States
Tel: +1-415-520-1050

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Diffuse Large B-Cell Lymphoma Market | AstraZeneca plc, Astellas Pharma, Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd here

News-ID: 1777117 • Views: 9294

More Releases from TMR Research

Nut Oils and Butters Market to Register Unwavering Growth During 2028
Nut Oils and Butters Market: Snapshot Over the past few years, nut oils and butters have gained immense popularity with the demand for tasty food products that pack loads of nutrients. In part the popularity is driven by the rising demand for plant-based butters and oils in health-conscious populations. Changing food habits have fueled the integration of plant-based oils and butters in regular diet in various parts of the world. This
Isomalt Market Projected to Witness Vigorous Expansion by 2028
Global Isomalt Market: Snapshot Isomalt, a sugar substitute, has an attractive sweetness profile. The low-hygroscopic substance can be combined with high-intensity sweetener such as sucralose to achieve a sweetener profile tailored to the need of end-use products. For instance, isomalt has gathered steam in cake decoration. The key reason for this that isomalt doesn’t caramelize due to heat unlike normal sugar. Further, it can be molded in various shapes and can
White Chocolate Market Expected to Expand at a High CAGR By End of 2025
Global White Chocolate Market: Snapshot The market for white chocolate is expanding as a result of its application wherever this lighter derivative is more useful than those siblings that contain cocoa solids. Considered among the most fragile forms of chocolate that requires close attention while heating and its deliciousness and authenticity, the demand for white chocolate is anticipated to expand consistently in the near future. Get Brochure of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=3266 The
Synthetic Food Market to Witness Widespread Expansion During 2025
Global Synthetic Food Market: Overview Synthetic food refer to any variety of consumable that are produced with the help of biotechnological methods from a set of nutritive substances, such as fats, vitamins, proteins or their components, and trace elements. The end result of these processes is a product that imitates natural foods by the recreation of color, flavor, appearance, nutritional value, and palatability. The concept of these food products may seem

All 5 Releases


More Releases for Diffuse

Diffuse Large B-Cell Lymphoma Market - Cutthroat Competition Prophesy 2025 | Amg …
Global Diffuse Large B-cell Lymphoma Market: Snapshot Lymphoma is a type of cancer affecting the human lymphatic system, a part of our immune system. The development of lymphoma begins when a type of white bold cell, lymphocytes commence to divide in an uncontrolled manner. Although there are two chief kinds of lymphocytes, T lymphocytes and B lymphocytes, B cells tend to be responsible for most lymphomas. Diffuse large B-cell lymphoma (DLBCL)
Diffuse Large B-Cell Lymphoma Market Rigorous Period of 2025 - Amgen, Inc., Astr …
Global Diffuse Large B-cell Lymphoma Market: Snapshot Lymphoma is a type of cancer affecting the human lymphatic system, a part of our immune system. The development of lymphoma begins when a type of white bold cell, lymphocytes commence to divide in an uncontrolled manner. Although there are two chief kinds of lymphocytes, T lymphocytes and B lymphocytes, B cells tend to be responsible for most lymphomas. Diffuse large B-cell lymphoma (DLBCL)
Global Diffuse Large B Cell Lymphoma Drug Market 2018 - AbbVie, BeiGene, Celltri …
Apex Market Reports, recently published a detailed market research study focused on the “Diffuse Large B Cell Lymphoma Drug Market” across the global, regional and country level. The report provides 360° analysis of “Diffuse Large B Cell Lymphoma Drug Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and
Diffuse Large B-Cell Lymphoma Market Analysis by Global Segments, Size and Forec …
Global Diffuse Large B-cell Lymphoma Market: Snapshot Lymphoma is a type of cancer affecting the human lymphatic system, a part of our immune system. The development of lymphoma begins when a type of white bold cell, lymphocytes commence to divide in an uncontrolled manner. Although there are two chief kinds of lymphocytes, T lymphocytes and B lymphocytes, B cells tend to be responsible for most lymphomas. Diffuse large B-cell lymphoma (DLBCL)
Diffuse Large B-Cell Lymphoma Market Report 2017 Analysis & Research
Diffuse Large B-Cell Lymphoma Market: Overview With a noticeable rise in the prevalence of diffuse large B-cell lymphoma (DLBCL), the market for DLBCL market is witnessing strong growth across the world. Analysts expect the trend to remain so over the next few years, owing to the increasing number of elderly people, the most prone to DLBCL segment of the overall population. Diffuse large B-cell lymphoma (DLBCL) is the most common
Product Overview And Scope Of Diffuse Large B-Cell Lymphoma Market For 2017 - 20 …
Diffuse Large B-Cell Lymphoma Market: Overview With a noticeable rise in the prevalence of diffuse large B-cell lymphoma (DLBCL), the market for DLBCL market is witnessing strong growth across the world. Analysts expect the trend to remain so over the next few years, owing to the increasing number of elderly people, the most prone to DLBCL segment of the overall population. Diffuse large B-cell lymphoma (DLBCL) is the most common